Tricuspid Regurgitation, the Once-Forgotten Valve: Current Management Options and Remaining Gaps After the 2025 European Society of Cardiology Guidelines Update.
Historically considered a “neglected” valvular disease, moderate-to-severe tricuspid regurgitation (TR) is now recognized as an important contributor to morbidity, mortality, and right-sided heart failure (HF). Natural history studies show that significant TR is frequently associated with left-sided valve disease, particularly mitral valve disease, and independently predicts poor outcomes as severity increases. The 2025 European Society of Cardiology (ESC)/European Association for Cardio-Thoraci...